Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to -$3.5 million.

  • Gossamer Bio's Free Cash Flow fell 12.91% to -$36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.5 million, marking a year-over-year decrease of 11134.02%. This contributed to the annual value of -$3.5 million for FY2024, which is 97.82% up from last year.
  • Per Gossamer Bio's latest filing, its Free Cash Flow stood at -$3.5 million for FY2024, which was up 97.82% from -$159.2 million recorded in FY2023.
  • Gossamer Bio's 5-year Free Cash Flow high stood at -$3.5 million for FY2024, and its period low was -$190.4 million during FY2021.
  • Over the past 3 years, Gossamer Bio's median Free Cash Flow value was -$159.2 million (recorded in 2023), while the average stood at -$116.7 million.
  • As far as peak fluctuations go, Gossamer Bio's Free Cash Flow dropped by 20.34% in 2020, and later surged by 97.82% in 2024.
  • Yearly analysis of 5 years shows Gossamer Bio's Free Cash Flow stood at -$177.9 million in 2020, then decreased by 7.07% to -$190.4 million in 2021, then climbed by 1.57% to -$187.4 million in 2022, then climbed by 15.09% to -$159.2 million in 2023, then surged by 97.82% to -$3.5 million in 2024.